Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 30, 2009
Influence of erythropoietin therapy on serum prohepcidin levels in dialysis patientsMahmut Arabul, Mustafa Gullulu, Yusuf Yilmaz, et al.
Mutation Research|July 18, 2013
Comparative genotoxic and cytotoxic effects of the oral antidiabetic drugs sitagliptin, rosiglitazone, and pioglitazone in patients with type-2 diabetes: a cross-sectional, observational pilot studyOzen Oz Gul, Nilufer Cinkilic, Cuma Bulent Gul, et al.
Iranian Journal of Kidney Diseases|May 22, 2013
Ki-67 proliferation index in renal biopsy samples of patients with systemic lupus erythematosus and its correlation with clinical findingsEdiz Dalkilic, Gulaydan Filiz, Mahmut Yavuz, et al.
Kidney & Blood Pressure Research|June 9, 2012
Effect of the direct renin inhibitor aliskiren in the prevention of experimental contrast-induced nephropathy in the ratAlla Eldeen Kedrah, Elif Ari, Yesim Alahdab, et al.
Clinical Biochemistry|February 17, 2009
Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver diseaseYusuf Yilmaz, Engin Ulukaya, Ozen Oz Gul, et al.
Journal of Clinical Medicine|June 13, 2025
Evaluation of Risk Factors for Kidney Function Decline and Chronic Kidney Disease in Living Kidney DonorsAysegul Oruc, Derya Pekin, Ceren Sevinc Kahraman, et al.
Nephrology (Carlton, Vic.)|May 15, 2015
Evaluation of serum Spondin 2 levels in the different stages of Type 2 diabetic nephropathySerdar Kahvecioglu, Metin Guclu, Yasemin Ustundag, et al.
International Urology and Nephrology|June 7, 2015
Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal functionCuma Bulent Gul, Abdulmecit Yildiz, Alparslan Ersoy, et al.
Metabolism: Clinical and Experimental|August 28, 2009
Comparative effects of pioglitazone and rosiglitazone on plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus patientsOzen Oz Gul, Ercan Tuncel, Yusuf Yilmaz, et al.
Endocrine|April 9, 2008
Arterial elasticity and plasma levels of adiponectin and leptin in type 2 diabetic patients treated with thiazolidinedionesOzen Oz, Ercan Tuncel, Salih Eryilmaz, et al.
Pageof 3